Capgemini is pleased to invite you to the Data Driven R&D Conference, that will take place on October 20th in Barcelona (PIER01 - Pl. Pau Vila, 1).
The spiralling costs of drug discovery and late-stage failures, together with phenomenal increased volumes of biomedical data has shifted drug discovery into a data-centric era. Life sciences and pharmaceutical companies are embracing these industry challenges, they are taking advantage of AI (Artificial Intelligence), Machine Learning (ML), data science and analytics in their R&D organizations. However, the biggest challenge they face is how to deliver this data-driven approach to drug discovery at scale across an entire organization; to accelerate critical research processes, automate insight generation and deliver better informed decision making and ultimately reduce time-to-patient for new medicines and therapies.
During this event we will explore what it means to be ‘Data-Driven’ and how to accelerate the transformation in R&D. We will also look at the next generation of new technologies like quantum computing which have the potential to revolutionize the discovery and development of new medicines.
Finally, there will be an opportunity to network and discuss success stories and digital R&D strategies with likeminded peers from across the Life science industry
Capgemini Engineering is the new Global Business Line of Capgemini, which consolidates a unique set of market leading capabilities in engineering and R&D. Along with the Group’s deep industry expertise and cutting-edge technologies in digital and software, it supports organizations as the digital and physical worlds converge. The global business line, with its 52,000 engineers and scientists and a presence in all major engineering hubs across the world, cover three key domains: product and systems engineering; digital and software engineering; and industrial operations.
Capgemini is a global leader in partnering with companies to transform and manage their business by harnessing the power of technology. The Group is guided everyday by its purpose of unleashing human energy through technology for an inclusive and sustainable future. It is a responsible and diverse organization of over 325,000 team members in more than 50 countries. With its strong 55-year heritage and deep industry expertise, Capgemini is trusted by its clients to address the entire breadth of their business needs, from strategy and design to operations, fueled by the fast evolving and innovative world of cloud, data, AI, connectivity, software, digital engineering and platforms. The Group reported in 2021 global revenues of €18 billion.
Get The Future You Want | www.capgemini.com
Registration form
Is your R&D Data Driven and ready for the challenges ahead?
Event data
20 de Octubre 2022
Añadir a la agenda
9:30 a 13:00 horas
Pier 01. Palau de Mar
Plaça Pau Vila, 1. 08003 Barcelona
https://goo.gl/maps/wUxQdVbs3LsC9nvK6
Francis Newson
Quantum Developer
Capgemini Engineering Hybrid Intelligence
|
09:30h |
Welcome coffee and registration |
| 10:00h | Welcome and introduction |
| 10:15h | Enable breakthrough innovations with the power of data. It takes over $1 billion and 12 years to bring a new drug to market. New technologies have huge potential to accelerate innovation and reduce costs, but many organisations struggle to realise the step change they anticipate from adopting them. We will discuss how organisations can overcome these challenges by examining real examples from pharmaceutical companies, from early stage discovery to manufacturing trials. |
| 10:45h | Round table: Is your organization Data Driven? |
| 11:30h | Coffee networking |
| 12:00h | Quantum computing: how to engage with an emerging technology in drug discovery In the coming decade, quantum computing brings the promise of developing new therapeutics faster and more efficiently. While several pharmaceutical organisations have started their exploration of the technology already, the path to future quantum advantage has many challenges and it is important to understand how to position investments in a way that drives value over time. We will give an overview of quantum computing in the life sciences and outline actions which organisations can take today as part of a successful roadmap for this emerging technology. |
| 12:30h | Conclusions |
| 12:40h | Life Sciences Networking |
James Downing
Data Driven R&D Consultant.
Capgemini Engineering
By submitting this form, I understand that my data will be processed by Capgemini Responsible: Capgemini España, S.L. - Purpose: Participation in a webinar and Commercial Relationship - Legitimation and Recipients: Consent / Entities of the same business group - Rights: Access, Rectification, Deletion, Limitation and Portability - Additional information: For more information, see the Privacy Policy.
Gonzalo Durban
Head of Data & Analytics
Almirall
Víctor González
Director de I+D
Atrys Health
Fátima Galán
Artificial Intelligence & Quantum Director
Capgemini Engineering
Oscar Flores
CEO
Genomcore
